Amotivational Syndrome and Fatigue in Neurosurgery
DENI-CARE
1 other identifier
observational
25
1 country
1
Brief Summary
Depression is a major public concern associated with profound distress, intense suffering, and impairment in social, professional and familial functioning. Among the numerous symptoms defining depression, fatigue and motivation are not only frequent but also highly associated with poor quality of life and resistance to conventional antidepressant. Recent data, mainly obtained in animals, suggest that these symptoms may be linked to inflammatory processes within the central nervous system. Yet access to the brain is too invasive for exploring this link in patients with psychiatric conditions. However, certain conditions in neurosurgery, such as aneurysm rupture, require external evacuation, over several days or weeks, of the fluid bathing the brain through a catheter directly inserted into it. Critically, these patients also exhibit extreme exhaustion and fluctuating motivation, allowing to investigate the involvement of neuroinflammation in lack of motivation and fatigue by carrying out repeated motivation assessments with short behavioral tests (around ten minutes), while performing an analysis of inflammation markers in the fluid evacuated from the brain. The identification of inflammatory mechanisms underlying lack of motivation and fatigue could lead to the development of treatments for both resistant depression and motivation deficits that largely hamper rehabilitation in neurosurgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2021
CompletedFirst Posted
Study publicly available on registry
May 28, 2021
CompletedStudy Start
First participant enrolled
December 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFebruary 17, 2023
February 1, 2023
2 years
May 25, 2021
February 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nerotransmitter levels in cerebrospinal fuid in relation to patient motivational condition
Study the correlation between serotonin, dopamin and glutamate concentrations in the cerebrospinal fluid with the motivational state of the patients
36 months
Study Arms (1)
Amotivational Syndrome
Patients required an external drainage of the cerebrospinal fluid.
Interventions
A motivational interviewing algorithm developed in Rothschild Hospital for this study will be used. The results range between 0% (worst motivational state) to 100% (best motivational state).
Eligibility Criteria
Patients required an external drainage of the cerebrospinal fluid
You may qualify if:
- Age \>= 18 years old
- Patients required an external cerebrospinal fluid drainage
You may not qualify if:
- Pregnant or breast feeding patient
- Patient under legal protection
- Patient opposition to participate in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Fondation Adolphe de Rothschild
Paris, Île-de-France Region, 75019, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2021
First Posted
May 28, 2021
Study Start
December 4, 2021
Primary Completion
December 4, 2023
Study Completion
December 1, 2024
Last Updated
February 17, 2023
Record last verified: 2023-02